HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $497,807 | +15.8% | 13,035 | +33.3% | 0.08% | +78.6% |
Q2 2022 | $430,000 | -3.8% | 9,782 | -6.6% | 0.04% | +35.5% |
Q4 2020 | $447,000 | -66.1% | 10,471 | -78.7% | 0.03% | -73.0% |
Q2 2020 | $1,319,000 | +129.8% | 49,216 | +52.1% | 0.12% | +45.6% |
Q4 2019 | $574,000 | – | 32,348 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |